FUTU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FUTU is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants to act now rather than wait for a better entry. The stock has solid revenue growth and strong hedge fund interest, but the technical trend is still weak, options sentiment is mixed, and regulatory/legal headlines are a real overhang. My direct call: hold, not buy today.
The technical picture is bearish. MACD histogram is -3.742 and still below zero, showing downside momentum remains in place. RSI_6 at 33.107 is weak but not yet deeply oversold. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend. Price at 104.97 is below the pivot of 114.237 and well under R1 at 138.059, while S1 is 90.416. The stock closed nearly flat versus the prior close, but the broader setup still favors caution. The model trend also suggests weakness over the next month.
["Q1 2026 revenue rose about 25% year over year to $746.9 million / HKD 5.9 billion, showing strong top-line growth.", "Total client assets reached $155.8 billion, reflecting healthy platform usage and asset gathering.", "Record trading volume of $529.4 billion supports transaction-based growth.", "Hedge funds are aggressively buying, with buying up 1234.10% over the last quarter.", "Some analysts remain constructive: Jefferies kept a Buy rating and Goldman had previously placed the stock on its APAC Conviction List."]
["Rosen Law Firm launched an investigation into potentially misleading business information, creating legal overhang.", "Net income dropped 61% despite revenue growth, showing weaker profitability.", "Goldman Sachs downgraded the stock to Neutral and sharply cut its target due to elevated regulatory uncertainty and remediation costs.", "The company faces fines, compliance remediation, and higher client acquisition costs in new markets.", "Technical trend remains bearish, and the stock is below key pivot resistance.", "Analyst targets have been cut materially across several firms, signaling reduced confidence in upside.", "Pattern-based stock trend data suggests a negative monthly bias."]
Latest quarter season: Q1 2026. Revenue increased 25% year over year to $746.9 million, which is strong growth. Client assets rose to $155.8 billion and trading volume reached a record $529.4 billion, both positive indicators of platform activity. The main weakness was profitability, as net income fell 61% year over year due to competition and regulatory pressure. So the quarter showed strong growth but weaker earnings quality.
Analyst sentiment has turned more mixed and less favorable recently. Jefferies kept a Buy rating but cut its target to $170.50 from $224. JPMorgan raised its target to $100 but kept Neutral. Goldman Sachs downgraded to Neutral from Buy and slashed its target to $102.13 from $210.47, citing regulatory uncertainty, fines, and higher costs. Earlier in the period, Barclays and Morgan Stanley were still positive but also lowered targets. Wall Street pros and cons view: pros are strong revenue growth, client expansion, and long-term franchise value; cons are regulatory risk, weaker net income, rising acquisition costs, and reduced near-term upside expectations.
